Rigel Announces Presentation at the Upcoming IDWeek 2023
AP News,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Showing items 1–100
Rigel Announces Presentation at the Upcoming IDWeek 2023
Stockwatch,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
MarketScreener,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KX News,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
MyChamplainValley.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Your Basin,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
News story from OZARKSFIRST.com on Wednesday 11 October 2023
OZARKSFIRST.com,
Rigel Announces Presentation at the Upcoming IDWeek 2023
KGET,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Wjtv.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WVNS-TV,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KOIN 6,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WPRI 12 Eyewitness News,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
CBS17.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
MyTwinTiers.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
ABC27,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Informnny,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WTRF 7 News,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WBOY,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
News story from News Channel 8 on Wednesday 11 October 2023
News Channel 8 ,
Rigel Announces Presentation at the Upcoming IDWeek 2023
YourErie.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Texomashomepage.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WBTW News13,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
abc8news,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
CIProud.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
MyHighPlains.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Kxan,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
News Channel 11 wjhl.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WOWKTV 13,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WGN9,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WSFA ,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Count on News 2,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KRQE,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Wlns.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WSAV3,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Everything Lubbock,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Myarklamiss.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
TriStateHomepage.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WLOX,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KCRG.com,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Benzinga,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WMTV nbc15,
Published: Oct. 11, 2023 at 7:05 AM CDT|Updated: moments ago -- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN…
Rigel Announces Presentation at the Upcoming IDWeek 2023
NEWS4,
Published: Oct. 11, 2023 at 7:05 AM CDT|Updated: 17 minutes ago -- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN…
Rigel Announces Presentation at the Upcoming IDWeek 2023
WFRV,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WBRC,
-- Provides Update on ACTIV-4 Host Tissue Trial --, - Rigel Pharmaceuticals, Inc.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WISTV,
-- Provides Update on ACTIV-4 Host Tissue Trial -- Details of the oral presentation at IDWeek 2023 are as follows: Abstract #…
Rigel Announces Presentation at the Upcoming IDWeek 2023
Morning Star,
Rigel Announces Presentation at the Upcoming IDWeek 2023 PR Newswire SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Yahoo! Finance USA,
Provides Update on ACTIV-4 Host Tissue Trial SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WAFB 9,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WALB,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Hawaii News Now,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KBTX-TV,
Published: Oct. 11, 2023 at 7:05 AM CDT|Updated: 8 minutes ago -- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN…
Rigel Announces Presentation at the Upcoming IDWeek 2023
Wave 3 News,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WECT News 6,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
FOX31 Denver KDVR-TV,
Please enter a search term. Please enter a search term. News provided by Oct 11, 2023, 8:05 AM ET -- Provides Update on ACTIV-4…
Rigel Announces Presentation at the Upcoming IDWeek 2023
KCBD,
Published: Oct. 11, 2023 at 7:05 AM CDT|Updated: 12 minutes ago -- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN…
Rigel Announces Presentation at the Upcoming IDWeek 2023
WCAX,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
News Channel 10,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
News story from WHSV3 on Wednesday 11 October 2023
WHSV3,
Rigel Announces Presentation at the Upcoming IDWeek 2023
KEYC News 12,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
South Carolina News Now,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
KAIT-TV,
SOUTH SAN FRANCISCO, Calif., Oct. 11, 2023 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WDAM - TV,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
kwtx,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Fox 19,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
NBC12,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
WBAY-TV,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
14 News,
-- Provides Update on ACTIV-4 Host Tissue Trial --, - Rigel Pharmaceuticals, Inc.
Rigel Announces Presentation at the Upcoming IDWeek 2023
PR Newswire,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
Rigel Announces Presentation at the Upcoming IDWeek 2023
Finanzen,
-- Provides Update on ACTIV-4 Host Tissue Trial -- SOUTH SAN FRANCISCO, Calif., Oct.
COVID-19 | Annals of Inside Medication
PressNewsAgency,
The COVID-19 pandemic has accounted for greater than 768 million instances and practically 7 million deaths globally up to now…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
VB Profiles,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
Spoke,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
AP News,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WAFB 9,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WTVM,
SOUTH SAN FRANCISCO, Calif., Nov. 3, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
Hawaii News Now,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
Fox 19,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WBRC,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WECT News 6,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KCBD,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
NBC12,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
Yahoo! Finance USA,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
Wave 3 News,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KBTX-TV,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WALB,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WCAX,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
South Carolina News Now,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WSFA ,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
14 News,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
News story from WHSV3 on Thursday 03 November 2022
WHSV3,
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WMTV nbc15,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KLTV,
Third quarter TAVALISSE® net product sales of $19.2 million and total revenues of $22.4 million Conference call and webcast…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KEYC News 12,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KAIT-TV,
SOUTH SAN FRANCISCO, Calif., Nov. 3, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
News Channel 10,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
KCRG.com,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WDAM - TV,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
WLOX,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update
PR Newswire,
FDA review ongoing for olutasidenib NDA; preparations underway for potential launch Third quarter TAVALISSE® net product sales…
Rigel Announces Top-line Results from FOCUS Phase 3 Clinical Trial of Fostamatinib in High Risk Hospitalized COVID-19 Patients
AP News,
SOUTH SAN FRANCISCO, Calif., Nov. 1, 2022 /PRNewswire/ -- Rigel Pharmaceuticals, Inc.
Showing items 1–100